Interesting to see that Capricor (CAPR) with a very second rate treatment for inflammation for DMD is currently up to US$150m market cap.
Their results do not come t near ours and they do not have the biological and MOA data that ANP also has.
Great to see interest in the space though.
James Garner AKA JG, page-102
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $81.13M | |||
| Open | High | Low | Value | Volume |
| 8.9¢ | 9.2¢ | 8.8¢ | $54.27K | 599.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 133829 | 9.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.1¢ | 30094 | 1 |
View Market Depth
| Last trade - 12.38pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
9.1¢ |
Change
0.000 ( 2.25 %) |
||||
| Open | High | Low | Volume | ||
| 8.9¢ | 9.1¢ | 8.8¢ | 122574 | ||
| Last updated 12.19pm 14/06/2024 ? | |||||
| PER (ASX) Chart |